title: Inhibition of enzymatic activity of phospholipases A2 by minocycline and doxycycline.
abstract: Extracellular phospholipases A2 play an important role in articular and extra-articular inflammatory processes. Secretory non-pancreatic phospholipase A2 (PLA2) has been implicated in the pathogenesis of articular inflammation in rheumatoid arthritis, whereas pancreatic PLA2 contributes to the tissue damage associated with acute pancreatitis. Since in experimental models lipophilic tetracyclines such as minocycline and doxycycline are antiinflammatory, we examined their effects on PLA2 activity using two assay systems in vitro. We found that minocycline and to a lesser degree doxycycline were markedly inhibitory to both pancreatic and non-pancreatic PLA2. Using [14C]oleic acid labeled Escherichia coli membrane phospholipids as substrate, the IC50 values for minocycline and doxycycline were 3.6 x 10(-5) M (18 micrograms/mL) and 0.98 x 10(-4) M (47 micrograms/mL), respectively. In a scooting mode assay using the synthetic phospholipid 1-palmitoyl-2-(10-pyrenedecanoyl)-3-L-phosphatidylmethanol as substrate, IC50 values for minocycline were 5 microM (2.47 micrograms/mL) for non-pancreatic PLA2 and 8 microM (3.95 micrograms/mL) for pancreatic PLA2. Addition of excess calcium up to 50 mM did not reverse the inhibitory activity of tetracyclines. We conclude that lipophilic tetracyclines inhibit PLA2, probably by interaction with the substrate, and may be a useful adjunct in the therapy of inflammatory conditions in which PLA2 is implicated pathogenetically.
authors.affiliation: Inflammation Research Group, Wellesley Hospital, University of Toronto, Ontario, Canada.
authors.forename: W
authors.initials: W
authors.lastname: Pruzanski
authors.forename: R A
authors.initials: RA
authors.lastname: Greenwald
authors.forename: I P
authors.initials: IP
authors.lastname: Street
authors.forename: F
authors.initials: F
authors.lastname: Laliberte
authors.forename: E
authors.initials: E
authors.lastname: Stefanski
authors.forename: P
authors.initials: P
authors.lastname: Vadas
mesh_terms: D000818:Animals; D004318:Doxycycline / Q000494:pharmacology*; D006801:Humans; D008911:Minocycline / Q000494:pharmacology*; D010195:Pancreatitis / Q000378:metabolism; D010741:Phospholipases A / Q000037:antagonists & inhibitors*; D054467:Phospholipases A2; D011994:Recombinant Proteins / Q000037:antagonists & inhibitors; D013552:Swine; D013582:Synovial Fluid / Q000201:enzymology; D013585:Synovitis / Q000378:metabolism
chemical_list: D011994:Recombinant Proteins; D010741:Phospholipases A; D054467:Phospholipases A2; D008911:Minocycline; D004318:Doxycycline